BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34660316)

  • 1. Identification of Therapeutic Targets and Prognostic Biomarkers Among Integrin Subunits in the Skin Cutaneous Melanoma Microenvironment.
    Nurzat Y; Su W; Min P; Li K; Xu H; Zhang Y
    Front Oncol; 2021; 11():751875. PubMed ID: 34660316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma.
    Xie H; Qin C; Zhou X; Liu J; Yang K; Nong J; Luo J; Peng T
    Medicine (Baltimore); 2023 Aug; 102(33):e34765. PubMed ID: 37603520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients.
    Huang B; Han W; Sheng ZF; Shen GL
    Cancer Cell Int; 2020; 20():195. PubMed ID: 32508531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer.
    Zhu T; Chen R; Wang J; Yue H; Lu X; Li J
    Cancer Cell Int; 2020; 20():257. PubMed ID: 32565741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
    Fan Y; Liang X; Yu D
    Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment.
    Zhou X; Peng M; He Y; Peng J; Zhang X; Wang C; Xia X; Song W
    Front Oncol; 2021; 11():619003. PubMed ID: 33767987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma.
    Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y
    BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of NLRP3 in the prognosis and immune infiltrates of skin cutaneous melanoma (SKCM).
    Wu S; Zang Q; Dai B
    Transl Cancer Res; 2021 Apr; 10(4):1692-1702. PubMed ID: 35116494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
    Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
    Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM2 interactions with mouse eggs and cell lines expressing α4/α9 (ITGA4/ITGA9) integrins: implications for integrin-based adhesion and fertilization.
    Desiderio UV; Zhu X; Evans JP
    PLoS One; 2010 Oct; 5(10):e13744. PubMed ID: 21060781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile and prognostic values of LSM family in skin cutaneous melanoma.
    Sun X; Zhang J; Xiao C; Ge Z
    BMC Med Genomics; 2022 Nov; 15(1):238. PubMed ID: 36371223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma.
    Long S; Xu J; Huang H
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of the paired box gene 3 inhibits the progression of skin cutaneous melanoma by inhibiting c-MET tyrosine kinase : PAX3 downregulation inhibits melanoma progression.
    Zhang K; Yu C; Tian R; Zhang W; Tang S; Wang G
    Mol Biol Rep; 2022 Oct; 49(10):9137-9145. PubMed ID: 36057879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer.
    Zhuang H; Zhou Z; Ma Z; Li Z; Liu C; Huang S; Zhang C; Hou B
    J Cell Mol Med; 2020 Nov; 24(22):13481-13493. PubMed ID: 33073486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM).
    Zhang S; Chen K; Zhao Z; Zhang X; Xu L; Liu T; Yu S
    J Immunother; 2022 Jul-Aug 01; 45(6):274-283. PubMed ID: 35543550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of SNHG16(lncRNA)-Hsa-Let-7b-5p(miRNA)-TUBB4A (mRNA) Pathway Fuels Progression of Skin Cutaneous Melanoma.
    Chen G; Yan J
    Curr Protein Pept Sci; 2022; 23(11):791-809. PubMed ID: 36173063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients.
    Wang X; Xiong H; Liang D; Chen Z; Li X; Zhang K
    BMC Cancer; 2020 May; 20(1):378. PubMed ID: 32370744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implication and functional annotations of APOBEC3G expression in patients with Melanoma.
    Han W; Xu J; Shen GL
    J Cancer; 2020; 11(17):5245-5256. PubMed ID: 32742470
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of CD38 as a potential biomarker in skin cutaneous melanoma using bioinformatics analysis.
    Wang X; Wang P; Ge L; Wang J; Naqvi SMAS; Hu S
    Oncol Lett; 2020 Oct; 20(4):12. PubMed ID: 32774485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and immune-related value of STK17B in skin cutaneous melanoma.
    Shi X; Zhou Q; Huang B; Xia S; Jiang Y; Fang S; Lin J
    PLoS One; 2022; 17(2):e0263311. PubMed ID: 35171924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.